GSLLX
Price
$20.06
Change
+$1.69 (+9.20%)
Updated
Apr 9 closing price
Net Assets
351.88M
RWMFX
Price
$59.75
Change
+$4.29 (+7.74%)
Updated
Apr 9 closing price
Net Assets
167.99B
Ad is loading...

GSLLX vs RWMFX

Header iconGSLLX vs RWMFX Comparison
Open Charts GSLLX vs RWMFXBanner chart's image
Goldman Sachs Enh Core Eq Fund-InvShares
Price$20.06
Change+$1.69 (+9.20%)
VolumeN/A
Net Assets351.88M
American Funds Washington Mutual R5
Price$59.75
Change+$4.29 (+7.74%)
VolumeN/A
Net Assets167.99B
GSLLX vs RWMFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSLLX vs. RWMFX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSLLX is a Buy and RWMFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWMFX has more cash in the bank: 168B vs. GSLLX (352M). RWMFX pays higher dividends than GSLLX: RWMFX (1.53) vs GSLLX (0.54). GSLLX was incepted earlier than RWMFX: GSLLX (17 years) vs RWMFX (23 years). GSLLX (1.00) is less costly to investors than RWMFX (0.31). GSLLX is a more actively managed with annual turnover of: 79.00 vs. RWMFX (31.00). GSLLX has a lower initial minimum investment than RWMFX: GSLLX (0) vs RWMFX (250). GSLLX annual gain was more profitable for investors over the last year : -7.41 vs. RWMFX (-8.19). GSLLX return over 5 years is better than : 63.49 vs. RWMFX (44.88).
GSLLXRWMFXGSLLX / RWMFX
Total Expense Ratio0.680.31219%
Annual Report Gross Expense Ratio1.000.31323%
Fund Existence17 years23 years-
Gain YTD-15.927-9.504168%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets352M168B0%
Annual Yield % from dividends0.541.5335%
Returns for 1 year-7.41-8.1991%
Returns for 3 years10.58-2.62-404%
Returns for 5 years63.4944.88141%
Returns for 10 years48.5342.44114%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARCC20.881.97
+10.42%
Ares Capital Corp
FDMT2.760.25
+9.76%
4D Molecular Therapeutics
EVOK2.230.16
+7.73%
Evoke Pharma, Inc.
CWEN28.051.31
+4.90%
Clearway Energy
MCBS26.671.18
+4.63%
MetroCity Bankshares